BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will ...

(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...

BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a pharmaceutical company with a market capitalization of $14.83 million, announced today the implementation of a 1-for-16 reverse stock split of its common ...

A University of Ottawa neuroscientist has led a Canadian research team to reveal important new insights into the activation ...

Dyne Therapeutics Inc.-5.60% $1.56B ...

Brain samples contained 10 times more microplastics than other organs. The brain may contain higher -- and more significant -- amounts of microplastics than other organs in the body, according to ...

Routine Brain MRI Screening in Asymptomatic Late Stage Breast Cancer Patients Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer ...

Largest Study Ever Done on Cannabis and Brain Function Finds Impact on Working Memory Jan. 28, 2025 — A new study explores the effects of both recent and lifetime cannabis use on brain function ...

After hours: February 7 at 5:50:10 PM EST Loading Chart for NKTR ...

After hours: February 7 at 5:22:38 PM EST Loading Chart for PTIX ...

Sanofi S.A. Part Cert 0.02% €8.03M ...

Johnson & Johnson (J&J) MedTech announced on the 6th that it has signed an exclusive distribution and promotion agreement for 'Novosis' with CG MedTech and its subsidiary, CGBio. With this ...